BioCardia Inc (BCDA) shares skyrocketed on Thursday after receiving FDA clearance for its Morph DNA Steerable Introducer product family, designed to facilitate medical instrument insertion during cardiovascular procedures. The company expects this new product line to enhance outcomes for a variety of interventional procedures.